TELA Bio, Inc. (TELA)

NGM – Real vaqt narxi. Valyuta: USD

0.73

-0.06 (-7.97%)

Bozor ochiq: Aug 12, 2026, 3:20 PM EDT

0.77

-0.02 (-2.25%)

Oldingi bozordan keyin: Aug 11, 2026, 7:38 PM EDT

11.08.2026

TELA Bio, Inc. (TELA) Q2 2026 Earnings Call Transcript

10.08.2026

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

TELA Bio, Inc. (TELA) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.22 per share a year ago.

05.08.2026

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Aug. 05, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Board of Directors of TELA Bio approved inducement grants of stock options to purchase an aggregate of 2,370,000 shares of its common stock and restricted stock units covering 500,000 shares of its common stock to the Company's newly-hired Chief Executive Officer, Heather Getz, with a grant date of August 3, 2026 (the "Getz Grant Date"). The stock options consist of (i) stock options to purchase 1,365,000 shares of common stock (the “Standard Options”) and (ii) premium-priced stock options to purchase 1,005,000 shares of common stock (the “Premium-Options”). Additionally, the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 95,500 shares of its common stock to 11 newly-hired employees, with a grant date of August 4, 2026. The stock options and the restricted stock units discussed above were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of Ms. Getz's and each individual's employment compensation and were granted as an inducement material to his or her acceptance of employment with TELA Bio.

04.08.2026

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

MALVERN, Pa., Aug. 04, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio” or the “Company”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, announced that the Board of Directors (the “Board”) has appointed Heather Getz as Chief Executive Officer and Director, effective today.

Videolar

No Data

There is no data to display

Press-relizlar

05.08.2026

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04.08.2026

TELA Bio, Inc. (TELA)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

TELA Bio, Inc. (TELA)

TELA Bio, Inc. (TELA) Q2 2026 Earnings Call Transcript

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

Videolar

No Data

Press-relizlar

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

TELA Bio, Inc. (TELA) Q2 2026 Earnings Call Transcript

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

Videolar

No Data

Press-relizlar

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

Search stocks

TELA Bio, Inc. (TELA)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

TELA Bio, Inc. (TELA)

TELA Bio, Inc. (TELA) Q2 2026 Earnings Call Transcript

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

Videolar

No Data

Press-relizlar

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

TELA Bio, Inc. (TELA) Q2 2026 Earnings Call Transcript

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

Videolar

No Data

Press-relizlar

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director